| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.55B | 13.42B | 11.43B | 9.90B | 10.05B | 10.93B |
| Gross Profit | 8.79B | 7.61B | 5.69B | 4.32B | 4.56B | 6.19B |
| EBITDA | 8.92B | 8.02B | 6.54B | 5.12B | 5.38B | 6.86B |
| Net Income | 4.97B | 4.33B | 3.38B | 2.43B | 2.64B | 3.40B |
Balance Sheet | ||||||
| Total Assets | 21.93B | 21.38B | 18.71B | 16.73B | 17.28B | 18.30B |
| Cash, Cash Equivalents and Short-Term Investments | 5.35B | 4.91B | 3.50B | 1.75B | 2.28B | 3.49B |
| Total Debt | 7.40B | 7.41B | 7.00B | 7.03B | 7.10B | 7.46B |
| Total Liabilities | 10.07B | 10.28B | 9.48B | 9.24B | 9.13B | 10.09B |
| Stockholders Equity | 11.79B | 11.04B | 9.17B | 7.42B | 8.08B | 8.15B |
Cash Flow | ||||||
| Free Cash Flow | 4.28B | 3.43B | 3.39B | 2.56B | 1.85B | 3.40B |
| Operating Cash Flow | 5.73B | 4.75B | 4.42B | 3.57B | 2.80B | 4.29B |
| Investing Cash Flow | -1.67B | -1.68B | -673.30M | -1.40B | -666.80M | -972.90M |
| Financing Cash Flow | -3.26B | -2.01B | -1.65B | -3.10B | -3.01B | -2.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $122.88B | 9.00 | 25.22% | 0.95% | 25.14% | 73.19% | |
74 Outperform | $207.60B | 6.78 | 21.41% | 3.55% | 1.04% | -9.88% | |
72 Outperform | $151.92B | 22.35 | 45.96% | 2.07% | 21.70% | 36.79% | |
71 Outperform | $87.51B | 24.09 | 14.52% | 1.25% | 5.41% | ― | |
69 Neutral | $178.76B | 6.00 | 16.59% | 4.60% | 7.59% | -13.66% | |
66 Neutral | $70.21B | 8.97 | 7.68% | 10.04% | 4.64% | -51.66% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |